


Prexton announces initiation of phase II clinical testing in Parkinson’s disease

Lung cancer: Vaxon announces results of its Vx-001 therapeutic vaccine Phase IIb trial

ASCO 2017: CarThera to present data from phase 1/2a study
Minoryx Therapeutics successfully completes phase 1 clinical trial for lead candidate MIN-102
